EUVIMEDEUVIMED entdecken
Crossref

Intervertebral disc degeneration, inflammation, and bioactive lipids

Undurti Das, Ahmet Hacımüftüoğlu

Recent Trends in Pharmacology · 2024

DOI: 10.62425/rtpharma.1589019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Trends in Pharmacology, 2024. Verfasst von Undurti Das und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intervertebral disc degeneration, inflammation, and bioactive lipids Intervertebral disc degeneration Intervertebral disc (IVD) degeneration is a common condition that is associated with significant morbidity. There is no specific treatment available for IVD except for surgical intervention. IVD is an inflammatory condition. I propose that IVD can be prevented and managed by local administration of lipoxin A4 (LXA4), a potent anti-inflammatory, cytoprotective and anti-osteoporotic metabolite formed from arachidonic acid (AA). Keywords: intervertebral disc, degeneration, lipoxin A4, arachidonic acid, inflammation.

Zitieren

APA

Das, U., & Hacımüftüoğlu, A. (2024). Intervertebral disc degeneration, inflammation, and bioactive lipids. Recent Trends in Pharmacology. https://doi.org/10.62425/rtpharma.1589019

Vancouver

Das U, Hacımüftüoğlu A. Intervertebral disc degeneration, inflammation, and bioactive lipids. Recent Trends in Pharmacology. 2024. doi:10.62425/rtpharma.1589019

BibTeX
@article{Das2024,
  author = {Das, Undurti and Hacımüftüoğlu, Ahmet},
  title = {Intervertebral disc degeneration, inflammation, and bioactive lipids},
  journal = {Recent Trends in Pharmacology},
  year = {2024},
  doi = {10.62425/rtpharma.1589019}
}
Kostenlos starten →